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Abstract
Background: The implementation of magnetic resonance imaging (MRI) guided radiotherapy (RT) continues to
increase. Very limited in-vitro data on the interaction of ionizing radiation and magnetic fields (MF) have been
published. In these experiments we focused on the radiation response in a MF of the TK6 human lymphoblastoid
cells which are known to be highly radiosensitive due to efficient radiation-induced apoptosis.
Methods: Clonogenicity was determined 12–14 days after irradiation with 1–4 Gy 6 MV photons with or without
a 1.0 Tesla MF. Furthermore, alterations in cell cycle distribution and rates of radiation induced apoptosis (FACS
analysis of cells with sub-G1 DNA content) were analyzed.
Results: Clonogenic survival showed an exponential dose-dependence, and the radiation sensitivity parameter
(α = 1.57/Gy) was in accordance with earlier reports. Upon comparing the clonogenic survival between the
two groups, identical results within error bars were obtained. The survival fractions at 2 Gy were 9% (without
MF) and 8.5% (with MF), respectively.
Conclusion: A 1.0 Tesla MF does not affect the clonogenicity of TK6 cells irradiated with 1–4 Gy 6MV photons.
This supports the use of MRI guided RT, however ongoing research on the interaction of MF and radiotherapy is
warranted.
Keywords: MRI guided radiotherapy, MR Linac, In-vitro experiment, Normal human cells, TK6 human
lymphoblastoid cells
Introduction
Magnetic resonance image (MRI) guided radiation ther-
apy (RT) is rapidly expanding owing to the superior soft
tissue contrast compared with computer tomography (CT)
[1]. Despite the tremendous effort in developing suitable
technologies, concerns about possible alterations in bio-
logical responsiveness to a given therapeutic radiation dose
in the presence of a magnetic field (MF) has found much
less attention. While it is consented that current clinical
MRI technologies can be safely applied [2], some observed
physiological alterations [3] could become relevant when
radiation damage is concomitantly being processed in a
cell. However, such arguments are mere speculation at
present. More obvious is the possibility that the released
secondary electrons after photon energy absorption are
subject to the Lorentz force in a MF. This would not only
cause distortions of dose distribution at air/tissue inter-
faces [4] but could hypothetically also lead to clustering of
DNA damage from such “backcircling” electrons [5, 6].
Only a few researchers have addressed this subject experi-
mentally using different model systems, from baker’s yeast
[7] to mouse mammary tumor cells [8] or Chinese hamster
lung cells [9]. The common finding of these studies is a
lack of statistically significantly increased radiation re-
sponse due to static MF with field strength ranging from
0,14 to 2 Tesla. A similar observation was reported from
our laboratory where the clonogenic survival of human
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tumor cells (WIDR colon adenocarcinoma and A549
lung carcinoma) was assessed after 6 MV photons (up
to 8 Gy) with the absence or presence of a 1 Tesla
static MF [10]. However, due to potential hazards from
some unknown interaction phenomenon in the ioniz-
ing radiation-MF combination, it is reasonable to as-
sume that the normal tissue cell response rather than
the tumor cell response would be a more relevant
question. Therefore, we assessed the radiation response
of the TK6 human lymphoblastoid cells which are
known to be highly radiosensitive due to efficient radiation-
induced apoptosis; a mechanism frequently decreased
or abrogated in tumor cells [11, 12].
Methods
Cell culture
The TK6 cell line with wild type p53 function was
used in our experiments. TK6 cells (human lympho-
blastoid cells from spleen) were originally provided by
the Tumorbank of the German Cancer Research Cen-
ter, DKFZ, Heidelberg, Germany. DNA cell line authenti-
cation was done by Eurofins Medigenomix Forensik
GmbH, Ebersberg, Germany.
Identical to Schäfer’s work [11], the cells were cultured
in suspension at 37 °C in a humidified atmosphere (6%
CO2). The medium used was RPMI 1640 fortified with
10% heat-inactivated horse serum (Gibco) and 1% peni-
cillin. The cell density was kept at 0.1 to 1.0 × 106/ml by
subculturing at regular intervals.
Magnetic field
The MF was generated using a pair of magnetic coils with
an adjustable distance between the two poles, where MF
of up to 1.5 Tesla can be generated upon allowing an elec-
tric current to flow to the coils. The amount of current
needed to generate the desired MF strength was previ-
ously determined using a probe placed between the coils,
from which the MF strength can be read off. A special
container made of VeroClear RGD810 (Fig. 1) was then
placed between the poles, creating a 3.5 cm space between
the poles, in which the test tube containing the cells were
to be placed. To help dissipate the heat generated from
the electric current, creating a water-cooling system en-
sured a constant water flow into and out of the phantom,
such that no cell deaths occurred due to overheating.
Using the in-room laser positioning system, the cells were
placed in the isocenter of the linear accelerator. Following
the setup in Ziles’ work [10], the irradiation field was 10
cm in length and 3.3 cm in width, which covers the whole
tube containing the cells. The overall experiment setup
with its relevant parameters can be seen in Figs. 1 and 2.
Radiation and Clonogenic survival
Photon beams were generated using a linear accelerator
model Siemens Artiste 2 (6 MV) at the German Cancer
Research Center (DKFZ). The clonogenic survival of the
TK6 cells was determined by plotting their survival
curves with and without MF. Raw data of vitality are ob-
tained as plating efficiencies, and these values are deter-
mined in at least three independent experiments. Since
Fig. 1 (a) A blueprint of the apparatus that was used in our experiments along with its dimensions measured in mm (b). © Armin Runz, DKFZ
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our cells are not adherent in nature, the microtiter assay
using the 96 well plates was used. Cultured cells were
centrifuged, their supernatant discarded and then resus-
pended with 10ml fresh medium.
A concentration of 3.0 × 105 cells ml− 1 was then used
for each test tube. The test tubes were chilled on ice in
an ice box before and after irradiation to slow down
any metabolic processes. After irradiation the cells were
to be plated in the 96 wells such that each well has a
specific number of cells. Table 1 summarizes the num-
ber of cells used in our experiments, according to their
radiation types and respective doses. This number was
determined through several pilot tests, such that the
number of wells without cell colony after irradiation
lies between 40 and 50 (see eq. (1)).
After 14 days the number of wells which have changed
in color from red to yellow was counted for further
calculations.
The plating efficiency (PE) is calculated as such:
PE ¼ 1
N
∙ ln
96
n
 
ð1Þ
Where N = the number of cells plated in a well, n = the
number of wells without cell growth. Schäfer’s work has
shown that n should lie between 40 and 50 to obtain
stable results [11].
a
b
Fig. 2 Diagrams showing the experimental set-up (not drawn to scale) in lateral (a) and aerial (b) views
Table 1 The number of cells plated within a single well after
irradiation with respect to the type of radiation used in the
experiments
Type of radiation Dose [Gy] Number of cells per well
Photon beams 0 1
1 2
2 20
3 50
4 100
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With the PE value, the survival fraction (SF) is then
expressed as:
SF ¼ PE treatmentð Þ
PE controlð Þ ð2Þ
Where PE (control) is the plating efficiency obtained
at 0 Gy (with and without MF) and PE (treatment) is the
one obtained after the cells are irradiated. From three in-
dependent experiments the mean SF along with its
standard deviation for each dose was also calculated
(corrected to three decimal places or at least three sig-
nificant figures). A 2-sample t-test was then performed
comparing the two mean values between the control
group (without MF) and treatment group (with MF).
The difference between the two mean values is statisti-
cally significant when the p-value is < 0.05. A regres-
sion analysis was then performed following the linear
quadratic model (LQ-model), which then defines the
SF as an exponential function of the dose (D):
SF ¼ e −αD−βD2ð Þ ð3Þ
α and β are coefficients that can then be determined
using the regression analysis.
Fluorescence-activated cell sorting (FACS)
FACS was used to determine the shift in the cell cycle
population as well as the treatment specific apoptosis.
Past works have demonstrated the reliability of this
method to determine the rate of radiation-induced apop-
tosis [13]. Irradiated cells were cultured in a new flask
containing a new medium for 8, 10, 12, 14, 24 and 48 h
respectively, after which the cells were fixated using 1ml
of 80% alcohol and stored in the refrigerator at 10 °C.
For analysis, the alcohol solution was discarded and the
Table 2 The mean survival fractions (SF) of 3 independent experiments with and without MF with the respective t-test and p values
Dose [Gy] Mean SF (without MF) σ Mean SF (with MF) σ t-test p-value
0 1.191 0.238 1.155 0.162 0.217 0.840
1.0 0.286 0.0800 0.286 0.0679 0.00 1.00
2.0 0.0698 0.0251 0.0563 0.0202 0.726 0.510
3.0 0.0246 0.00904 0.0220 0.0130 0.284 0.792
4.0 0.00915 0.00398 0.00767 0.00444 0.430 0.690
Fig. 3 The survival curve generated after regression analysis following the LQ model. Note the proximity of the two curves (with or without
magnetic field (MF)) and the overlapping error bars between the mean survival fractions
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cells centrifuged. Afterwards they were rinsed with 2ml
of phosphate-buffered saline (PBS) twice (with centrifu-
gation and supernatant discard after each rinse). To
stain them, we added 900 μl of PBS and 100 μl of propi-
dium iodide. The tubes were kept in the refrigerator at
10 °C for 12 h to maximize staining. The changes in the
percentage of cells in each phase could thereby be
tracked. To measure the rate of apoptosis after treat-
ment, the percentage of sub-G1 population of the cells
was determined. Afterwards, the treatment-specific
apoptosis (TSA) was calculated with the aid of the fol-
lowing formula:
TSA ¼ f x− f 0
1− f 0
ð4Þ
Where fx is the total sub-G1-phase fraction after treat-
ment and f0 is the respective value of the untreated con-
trol (non-irradiated cells) from the same experiment.
We performed four repeats of this experiment independ-
ently and calculated the mean TSA. Similar to the sur-
vival assay, a two-sample unpooled t-test was also
performed to determine whether the differences in the
TSA between the two groups (with and without MF)
are statistically significant. Here the difference be-
tween the two mean values is statistically significant
when the p-value is < 0.05 as well.
Two-factor analysis of variance (two-way ANOVA)
We decided to include two-way ANOVA as an add-
itional statistical tool, which compares all variances in
the control group to those in the treatment group. This
analysis was generated using SPSS 23 by IBM.
Results
Clonogenic assay
Table 2 shows the mean SF of TK6 human lymphoblas-
toid cells after irradiation and 14 days incubation. Each
mean SF was calculated from 3 independent experi-
ments using the formulae previously described. The
corresponding t-test and p-values are listed. The sur-
vival curves are shown in Fig. 3.
Cell cycle analysis
Figure 4 shows the results of four identical, independent
FACS-analyses of the cell cycle progression (G1/G0, S
and G2) after photon irradiation of 4 Gy. After 12 h
the irradiated cells showed a significantly increased
number of cells in the G2 phase compared to the con-
trols (p-value < 0.05) regardless of the presence of a
MF. Furthermore, there was no significant difference
in the progression of the cell cycle between the cells
which were irradiated with a MF and those without a
MF (p-value > 0.05 for all time intervals and measurement
points). Hence, the MF has no influence on the cell cycle
progression after photon irradiation in TK6 cells.
Note the falling G0/G1 population with the simultan-
eous increase in G2 population over time in all four
Fig. 4 Cell-cycle analysis with the aid of FACS:(a) G1/G0 (b) S and
(c) G2 show the relative number of cells after irradiation with 4 Gy
photons (RT) with or without magnetic field (MF). Un-irradiated
controls were performed in each experiment. Error bars showed
the standard deviation of four independent experiments
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experiments. Also, the solid and dotted curves are al-
most identical for their respective cell cycle phase in
each experiment.
Treatment-specific apoptosis
Figure 5 shows the calculated treatment-specific apop-
tosis (TSA, eq. (4)) plotted against the incubation time
after irradiation. As expected, the TSA shows an up-
ward trend as the incubation time increases. The plotted
values are shown in Table 3 (corrected to two decimal
places or three significant figures).
Two-way ANOVA
The ANOVA tables of each measured parameter are
shown below (Tables 4 and 5). N = the number of
statistical cases. df = degree of freedom. F = F-value used
in two-way ANOVA. Sig. = Significance/p-value.
Discussion
The implementation of MRI-guided RT has been in-
creasing in recent years with new MR-Linacs being in-
stalled in various centers around the world. However,
only few data on the interaction of photon beam radi-
ation and MF have been published. In this developing
new field of RT, it is important to analyze potential
interaction phenomena in the ionizing radiation-MF
combination on tumor cell lines and normal tissue cell
lines as well. Therefore, the radiation response of TK6
human lymphoblastoid cells which are known to be
highly radiosensitive was analyzed as an indicator for
0 10 20 30 40 50 60
-0.1
0.0
0.1
0.2
0.3
0.4
Time/h
TSA w/o MF
TSA w/ MF
T
S
A
Fig. 5 Treatment-specific apoptosis (TSA) 8, 10, 12, 14, 24 and 48 h after irradiation of TK6 cell lines with 4 Gy photons both in the presence and
absence of a magnetic field (MF) of 1 Tesla
Table 3 The calculated mean TSA of both groups with their respective t-test and p values for each time period. Each mean value
was derived from 3 independent experiments
Time [h] Mean TSA (without MF) σ Mean TSA (with MF) σ t-test value p-value
8 0.0269 0.0326 0.0306 0.0115 0.182 0.869
10 0.0141 0.0157 0.0276 0.0174 1.004 0.373
12 0.0795 0.00738 0.0858 0.0366 0.292 0.796
14 0.0880 0.0194 0.0914 0.00279 0.303 0.790
24 0.171 0.0327 0.220 0.0288 1.58 0.191
48 0.339 0.0130 0.323 0.00534 1.59 0.222
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normal tissue interactions. Since most MRI used in
clinical settings utilize a MF of 0.5 to 1.5 T, our experi-
ments were carried out in a MF of 1 T.
Raw data of vitality were obtained as plating efficien-
cies, and these values were determined in at least three
independent experiments. Interexperimental variability
of data originates from both stochastic errors (i.e. preci-
sion of pipetting) and from systematic changes of bio-
logical factors. The latter is a common change of inherent
plating efficiency of a particular cell preparation – at a
given day and subcultivation history – which needs to be
accounted for by intraexperimental normalization before
repeat experiments can be compared. Accordingly, two
approaches can be distinguished: (i) all data (plating effi-
ciencies of a particular experiment) are normalized to the
respective control value yielding the surviving fractions in
the simplest manner. This procedure, however, implies
that the control value would have been determined with-
out error, which is not true. (ii) The mathematical func-
tion used to describe SF as a function of dose (the LQ
model) is fitted to all plating efficiencies of a particular ex-
periment (including control). This yields a calculated (“the
best”) value at dose zero which is then taken to normalize
the plating efficiencies for each independent experiment.
Subsequently, mean values (and standard deviations) from
the repeat measurements were calculated and the fit pro-
cedure (i.e. with LQ model) was applied again.
In our experiments the regression of the SF for the
photon beams produced a value of 1.57 for α, which is
an indicator of radiosensitivity of the cell type. The lin-
earity of the curve also confirms the radiosensitivity of
the TK6 cell line used. This corresponds to Schäfer’s
work [11] and therefore supports the reliability of the
chosen experimental setup.
Given the observation of a lacking influence with re-
gard to the MF, the respective statistical tests must be
considered. For the clonogenic assay a 2-sample t-test
was performed comparing the mean SF between the
control and experimental groups. It is then assumed that
the two groups that are being tested are independent of
each other and that they are normally distributed. The
unpooled t-test was selected since it is also assumed that
the variances are not equal. Since p > 0.05 in all dose
groups in all 3 different radiation types, it cannot be
concluded that there is a statistically significant differ-
ence between the two mean SF. Similar results were ob-
served when the TSA of both groups were compared
against each other. A p-value > 0.05 for all points in the
TSA graph also means that no conclusion about a statis-
tically significant difference between the mean TSA of
both groups can be reached. In other words, it cannot
be concluded that there is a biologically relevant effect
on TK6 cells after being irradiated in a MF.
In addition the two-way ANOVA test confirms our hy-
pothesis. The two independent variables are the pres-
ence of a MF and irradiation dose. The significant values
listed in all tables in the row “Magnetic_Field” are more
than 0.05, which indicates that at 5% significance level,
the presence of a MF does not have any statistically sig-
nificant effect on the dependent variable, be it SF or
TSA. Moreover, in the significant values in the row
“Magnetic_Field * Dose” are all close to 1.00, which
means that there is no interaction between those two
independent variables. Hence through these statistical
tests we can conclude that there are neither negative
nor positive effects observed when TK6 cells are irradi-
ated in a MF of 1 T.
In the cell cycle experiments we observed the well-
known G2-Arrest after photon irradiation [14]. The
addition of a MF had no significant influence on the cell
cycle progression after photon irradiation in TK6 cells
in our setting.
In another experiment from our laboratory on the clo-
nogenic survival of human tumor cells (WIDR colon
Table 4 Survival Fraction
Tests of Between-Subjects Effects
Dependent Variable: Survival Fraction
Source Type III Sum
of Squares
df Mean
Square
F Sig.
Corrected Model 5.875a 9 .653 68.657 .000
Intercept 2.896 1 2.896 304.610 .000
Magnetic Field .001 1 .001 .087 .770
Dose 5.873 4 1.468 154.421 .000
Magnetic Field * Dose .001 4 .000 .036 .997
Error .190 20 .010
Total 8.961 30
Corrected Total 6.065 29
a. R Squared = .969 (Adjusted R Squared = .955)
Table 5 Treatment-specific Apoptosis
Tests of Between-Subjects Effects
Dependent Variable: TSA
Source Type III Sum
of Squares
df Mean
Square
F Sig.
Corrected Model .427a 11 .039 69.808 .000
Intercept .560 1 .560 1007.354 .000
Magnetic Field .001 1 .001 1.601 .218
Time .422 5 .084 152.036 .000
Magnetic Field * Time .003 5 .001 1.223 .329
Error .013 24 .001
Total 1.000 36
Corrected Total .440 35
a. R Squared = .970 (Adjusted R Squared = .956)
Yudhistiara et al. Radiation Oncology           (2019) 14:11 Page 7 of 8
adenocarcinoma and A549 lung carcinoma cell lines)
treated with photon beam RT in a 1 Tesla MF, compar-
able results to this report were found [10].
In summary, the present phenomenological experi-
ment with normal human TK6 lymphoblastoid cell lines
as a highly radiosensitive in-vitro system does not indi-
cate any interaction of a static 1 Tesla MF on 1–4 Gy
photon beam RT. Further research on potential interac-
tions of MF and photon as well as particle beam treat-
ments is warranted.
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